ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Nicox SA

Nicox SA (NXOA)

0.00
0.00
( 0.00% )
Updated: -
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

NXOA Latest News

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Communiqué de presseNicox annonce la première...

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Press Release Nicox Announces First Commercial Sale of ZERVIATE in China...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results  Topline results from...

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Communiqué de presseNicox : Point financier sur le troisième trimestre 2024 et résultats...

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Communiqué de presse Nicox et Soleus signent un...

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Press Release Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Gross proceeds of $15 million (€13.7 million) for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
156000.43350.4360.4243910.42492589DE
260000.43350.4360.4243910.42492589DE

NXOA - Frequently Asked Questions (FAQ)

What is the current Nicox share price?
The current share price of Nicox is 0.00 €
What is the 1 year trading range for Nicox share price?
Nicox has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GTYGateway Real Estate AG
1.53 €
(213.52%)
552.62k
L7C2Windfall Geotek Inc
0.0145 €
(70.59%)
12.53k
6L6Senseonics Holdings Inc
0.547 €
(31.87%)
11.6k
O0KBayridge Resources Corp
0.067 €
(27.62%)
2k
97E0Vizsla Copper Corp
0.0484 €
(24.74%)
1.22k
E3O1Nexoptic Technology Corp
0.0095 €
(-44.12%)
22.48k
CNWCodon AG
0.007 €
(-36.36%)
25
D4GDataMetrex AI Ltd
0.0036 €
(-33.33%)
83k
L09Lithium Energi Exploration Inc
0.0155 €
(-31.11%)
47k
BR01Cruz Battery Metals Corp
0.0171 €
(-25.97%)
183.2k
PF8European Lithium Limited
0.0324 €
(8.00%)
2.75M
D7GNel ASA
0.2492 €
(0.20%)
1.97M
LHADeutsche Lufthansa AG
5.626 €
(-4.48%)
1.71M
QJ4Auric Minerals Corp
2.927 €
(9.52%)
1.23M
RQ0DWave Quantum Inc
6.286 €
(6.40%)
1.08M

Discussion

View Full Feed
TMaga TMaga 4 minutes ago
Did someone say $1.80 a share. Looks like $1.21 to me, down from the $10.00 IPO
Doing a 180 alright, with our share value and hard earned money that we got robbed out of with the largest R/S in OTC history.
HCWC
BIOCHEMUP BIOCHEMUP 4 minutes ago
Is the bull run over?
QBTS
plexrec plexrec 4 minutes ago
Awesome news---"Over at Stocktwits, someone has just posted a link to the Sabbagh"---it's all coming together !!! WGT !!!!
AVXL
KenKong KenKong 4 minutes ago
Yes. https://www.barrons.com/amp/articles/stock-market-open-closed-today-jimmy-carter-funeral-national-day-of-mourning-cc723714
FNMA
luvwetscent luvwetscent 4 minutes ago
"You're not going to have a big bump until shares are bought back"......Correctamundo
ELTP
JRoon71 JRoon71 4 minutes ago
Anti-hyperlipidemics

"Cardiovascular Agents" is a totally separate primary category.

Under Antihyperlipidemics:
*ACL INHIB-INTESTINAL CHOLESTEROL ABSORPTION INHIB COMB***
*ADENOSINE TRIPHOSPHATE-CITRATE LYASE (ACL) INHIBITORS***
*ANGIOPOIETIN-LIKE P
PULM
Hosai Hosai 4 minutes ago
Anyone know what this is George has posted? It gives the p values from the Sept 2023 PR, which are slightly higher than the recent ITT p values given at CTAD and in the main JPAD peer review paper. I think the Sept 2023 ones aren't the ITT so this is a different analsyis perhaps.

http
AVXL
WeTheMarket WeTheMarket 5 minutes ago
Key excerpt, Draft Environmental Assessment, Section 4, Page 41.
Link https://www.energy.gov/sites/default/files/2024-12/Limestone%20EA_draft%20clean%20120424%20.pdf

4. DRAFT FINDING

Based on this EA, DOE has determined that providing a federal loan guarantee to
PLUG
StayHumble StayHumble 6 minutes ago
💹🎃Per OTCM INSIDER $UBQU clears $2M💹debt in 12months💹💹 wow

https://www.otcmarkets.com/stock/UBQU/news/EQS-News-Ubiquitech-Software-Corp-OTCUBQU-Successfully-Eliminates-Additional-Convertible-Debt-Bringing-Recent-Total-Elim?id=444198
OTCM UBQU
vein vein 6 minutes ago
Honestly Zadie, it was just an article I read in linkdln. It was put out by checkpoint . 
CKPT
ruskie1 ruskie1 8 minutes ago
Chij … banana Bob has been saying that more times in the last 14 years than Pamela Anderson‘s body count… but he’ll quickly tell you it’s going to “ SOON “..lol
KBLB
frrol frrol 8 minutes ago
Yes, an historical control is far less reliable than placebo. If they add a third line for it, it will be helpful and interesting, but not conclusive. The best is to judge against baseline, ie "absolute" decline trend.

We may get an ADNI historical control line in the graphs and some
AVXL
SkeBallLarry SkeBallLarry 9 minutes ago
Good morning, EveryOne ~ 2-4" coming Fri, Nothing has melted .. !!
Pharmacydude Pharmacydude 9 minutes ago
The insurance company would argue that they are clarifying that generic IPE reduces triglycerides, whereas V has been shown to reduce cardiovascular events. The insurance company would argue that they informed the patient of the difference and the patient chose to use the generic. 
AMRN
Smartypants2 Smartypants2 10 minutes ago
JD was referring to nano fire protection, not hemp! https://news.yahoo.com/news/nano-labs-corp-ctle-announces-110000976.html
XERI
Buckey Buckey 10 minutes ago
I just do not talk politics partially because I would not consider myself terribly intelligent on that subject and also I do not really aspire to learn a lot. But I do find my right leaning friends tend to be more aggressive with their views so the group I play Hockey and Golf with we just have a
JusticeWillWin JusticeWillWin 11 minutes ago
Really no trading?

https://www.nasdaq.com/market-activity/stock-market-holiday-schedule

https://www.nyse.com/markets/hours-calendars

https://www.marketbeat.com/stock-market-holidays/

Tomorrow is national day of mourning and there is no trad
FNMA
surfkast surfkast 12 minutes ago
Obviously not! Some need help! LOL. I will try!

https://media1.tenor.com/m/59AOmo6T1dQAAAAd/mike-and-dave-need-wedding-dates.gif
HMBL
Invest-in-America Invest-in-America 12 minutes ago
REVG???
BAER
manibiotech manibiotech 12 minutes ago
Lol
Is that all you have
NWBO
glenn1919 glenn1919 13 minutes ago
baer.......................https://stockcharts.com/h-sc/ui?s=BAER&p=W&b=5&g=0&id=p86431144783
BAER
Guzzi62 Guzzi62 13 minutes ago
Pretty sloppy all way around!

Well it's only around 8 months ago he was hired, LOL.
AVXL
Gmenfan Gmenfan 13 minutes ago
I'll bet you miss it!! ;-)
Buckey Buckey 14 minutes ago
WTF are you serious? you buy insurance as a protection. This absolutely must be illegal. I can see them cancelling before an event but not in the middle

Your Recent History

Delayed Upgrade Clock